Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Hydrogen peroxide vapour treatment inactivates norovirus but has limited effect on post-treatment viral RNA levels.

Holmdahl T, Odenholt I, Riesbeck K, Medstrand P, Widell A.

Infect Dis (Lond). 2019 Mar;51(3):197-205. doi: 10.1080/23744235.2018.1546056. Epub 2019 Jan 16.

PMID:
30646786
2.

Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.

Hatti M, Solomonidi N, Odenholt I, Tham J, Resman F.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):485-493. doi: 10.1007/s10096-018-3194-x. Epub 2018 Jan 29.

3.

Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments.

Tängdén T, Karvanen M, Friberg LE, Odenholt I, Cars O.

Infect Dis (Lond). 2017 Jul;49(7):521-527. doi: 10.1080/23744235.2017.1296183. Epub 2017 Mar 6.

PMID:
28264618
4.

Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003-2010.

Skoog G, Struwe J, Cars O, Hanberger H, Odenholt I, Prag M, Skärlund K, Ulleryd P, Erntell M.

Euro Surveill. 2016 Jun 23;21(25). doi: 10.2807/1560-7917.ES.2016.21.25.30264.

5.

Hydrogen Peroxide Vapor Decontamination in a Patient Room Using Feline Calicivirus and Murine Norovirus as Surrogate Markers for Human Norovirus.

Holmdahl T, Walder M, Uzcátegui N, Odenholt I, Lanbeck P, Medstrand P, Widell A.

Infect Control Hosp Epidemiol. 2016 May;37(5):561-6. doi: 10.1017/ice.2016.15. Epub 2016 Feb 10.

PMID:
26861195
6.

An Audit-Based, Infectious Disease Specialist-Guided Antimicrobial Stewardship Program Profoundly Reduced Antibiotic Use Without Negatively Affecting Patient Outcomes.

Nilholm H, Holmstrand L, Ahl J, Månsson F, Odenholt I, Tham J, Melander E, Resman F.

Open Forum Infect Dis. 2015 Mar 23;2(2):ofv042. doi: 10.1093/ofid/ofv042. eCollection 2015 Apr.

7.

Prevalence of penicillin-non-susceptible Streptococcus pneumoniae in children in day-care centres subjected to an intervention to prevent dispersion.

Ahl J, Melander E, Odenholt I, Tvetman L, Thörnblad T, Riesbeck K, Ringberg H.

Infect Dis (Lond). 2015 May;47(5):338-44. doi: 10.3109/00365548.2014.994559. Epub 2015 Mar 6.

PMID:
25746603
8.

Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia.

Van Aken S, Lund N, Ahl J, Odenholt I, Tham J.

Scand J Infect Dis. 2014 Nov;46(11):753-62. doi: 10.3109/00365548.2014.937454. Epub 2014 Sep 8.

PMID:
25195648
9.

Risk factors for pneumococcal carriage in day care centers: a retrospective study during a 10-year period.

Ahl J, Melander E, Odenholt I, Tvetman L, Thörnblad T, Riesbeck K, Ringberg H.

Pediatr Infect Dis J. 2014 May;33(5):536-8. doi: 10.1097/INF.0000000000000146.

PMID:
24736443
10.

High incidence of septic shock caused by Streptococcus pneumoniae serotype 3--a retrospective epidemiological study.

Ahl J, Littorin N, Forsgren A, Odenholt I, Resman F, Riesbeck K.

BMC Infect Dis. 2013 Oct 22;13:492. doi: 10.1186/1471-2334-13-492.

11.

Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden.

Tham J, Odenholt I, Walder M, Andersson L, Melander E.

Infect Drug Resist. 2013 Sep 19;6:93-7. doi: 10.2147/IDR.S46290. eCollection 2013.

12.

Epidemiology of MRSA in southern Sweden: strong relation to foreign country of origin, health care abroad and foreign travel.

Larsson AK, Gustafsson E, Johansson PJ, Odenholt I, Petersson AC, Melander E.

Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):61-8. doi: 10.1007/s10096-013-1929-2. Epub 2013 Aug 8.

PMID:
23922169
13.

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food.

Tham J, Walder M, Melander E, Odenholt I.

Infect Drug Resist. 2012;5:143-7. doi: 10.2147/IDR.S34941. Epub 2012 Oct 16.

14.

Eradication of nasopharyngeal carriage of penicillin-non-susceptible Streptococcus pneumoniae--is it possible?

Hellberg M, Johansson S, Odenholt I, Holmdahl T, Ringberg H, Nilsson WP, Norrgren H, Ahl J.

Scand J Infect Dis. 2012 Dec;44(12):909-14. doi: 10.3109/00365548.2012.697636. Epub 2012 Sep 19.

PMID:
22991948
15.

Increase of β-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010.

Resman F, Ristovski M, Forsgren A, Kaijser B, Kronvall G, Medstrand P, Melander E, Odenholt I, Riesbeck K.

Antimicrob Agents Chemother. 2012 Aug;56(8):4408-15. doi: 10.1128/AAC.00415-12. Epub 2012 Jun 11.

16.

Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Tham J, Walder M, Melander E, Odenholt I.

Scand J Infect Dis. 2012 Aug;44(8):573-7. doi: 10.3109/00365548.2011.653582. Epub 2012 Jan 31.

PMID:
22292796
17.

Necrotizing myositis and septic shock caused by Haemophilus influenzae type f in a previously healthy man diagnosed with an IgG3 and a mannose-binding lectin deficiency.

Resman F, Svensjö T, Ünal C, Cronqvist J, Brorson H, Odenholt I, Riesbeck K.

Scand J Infect Dis. 2011 Dec;43(11-12):972-6. doi: 10.3109/00365548.2011.589079. Epub 2011 Jul 5.

PMID:
21728743
18.

Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden.

Strömdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1159-62. doi: 10.1007/s10096-011-1202-5. Epub 2011 Mar 12.

PMID:
21399889
19.

Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: a four-year experience from southern Sweden.

Larsson AK, Gustafsson E, Nilsson AC, Odenholt I, Ringberg H, Melander E.

Scand J Infect Dis. 2011 Jul;43(6-7):456-62. doi: 10.3109/00365548.2011.562530. Epub 2011 Mar 2.

PMID:
21366406
20.

[Penicillin V and how three dosages became two and than three again. History behind treatment of otitis, sinusitis and pharyngo-tonsillitis].

Giske CG, Eriksson M, Hermansson A, Kumlien J, Odenholt I, Cars O.

Lakartidningen. 2010 Oct 6-12;107(40):2392-5. Review. Swedish. No abstract available.

PMID:
21140570
21.

[New guidelines for vancomycin in staphylococcal infections].

Giske CG, Odenholt I, Kahlmeter G.

Lakartidningen. 2010 Mar 17-23;107(11):742. Swedish. No abstract available.

PMID:
20402263
22.

Bacterial aetiology in ventilator-associated pneumonia at a Swedish university hospital.

Ahl J, Tham J, Walder M, Melander E, Odenholt I.

Scand J Infect Dis. 2010 Jul;42(6-7):469-74. doi: 10.3109/00365541003621494.

PMID:
20370356
23.

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E.

Scand J Infect Dis. 2010 Apr;42(4):275-80. doi: 10.3109/00365540903493715.

PMID:
20121649
24.

[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime].

Hanberger H, Odenholt I, Giske CG, Kahlmeter G.

Lakartidningen. 2009 Jan 28-Feb 3;106(5):291-2. Swedish. No abstract available.

PMID:
19271459
25.

[General practitioners prescribed less antibiotics but used the CRP test more. Diagnosis-prescription studies in 2000-2005].

André M, Vernby A, Odenholt I, Lundborg CS, Axelsson I, Eriksson M, Runehagen A, Schwan A, Mölstad S.

Lakartidningen. 2008 Oct 8-14;105(41):2851-4. Swedish. No abstract available.

PMID:
19009899
26.

Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: consultations, diagnosis, diagnostics and treatment choices.

André M, Vernby A, Odenholt I, Lundborg CS, Axelsson I, Eriksson M, Runehagen A, Schwan A, Mölstad S.

Scand J Infect Dis. 2008;40(8):648-54. doi: 10.1080/00365540801932439.

PMID:
18979603
28.

Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.

Odenholt I, Walder M, Wullt M.

Chemotherapy. 2007;53(4):267-74. Epub 2007 Jun 25.

PMID:
17595541
29.

Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea.

Wullt M, Johansson Hagslätt ML, Odenholt I, Berggren A.

Dig Dis Sci. 2007 Sep;52(9):2082-6. Epub 2007 Apr 10.

PMID:
17420953
30.

[Treatment of patients with skin and soft tissue infections. Results from the STRAMA survey of diagnoses and prescriptions among general practitioners].

André M, Eriksson M, Odenholt I.

Lakartidningen. 2006 Oct 18-24;103(42):3165-7. Swedish. No abstract available.

PMID:
17111984
31.

Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Norén T, Wullt M, Akerlund T, Bäck E, Odenholt I, Burman LG.

Antimicrob Agents Chemother. 2006 Sep;50(9):3028-32.

33.

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Odenholt I, Rodloff A, Soussy CJ, Steinbakk M, Soriano F, Stetsiouk O.

Clin Microbiol Infect. 2006 Jun;12(6):501-3.

34.

The management of infections in children in general practice in Sweden: a repeated 1-week diagnosis-prescribing study in 5 counties in 2000 and 2002.

André M, Eriksson M, Mölstad S, Stålsbylundborg C, Jacobsson A, Odenholt I; Swedish Study Group on Antibiotic Use.

Scand J Infect Dis. 2005;37(11-12):863-9.

PMID:
16358447
36.

[Penicillin V should be administered three times daily].

Odenholt I, Cars O, Ostlund A, Erntell M.

Lakartidningen. 2004 Oct 7;101(41):3192. Swedish. No abstract available.

PMID:
15517722
37.
38.

The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned.

André M, Schwan A, Odenholt I; Swedish Study Group on Antibiotic Use.

Scand J Infect Dis. 2004;36(3):192-7.

PMID:
15119364
39.

Management of urinary tract infections in primary care: a repeated 1-week diagnosis-prescribing study in five counties in Sweden in 2000 and 2002.

André M, Mölstad S, Lundborg CS, Odenholt I; Swedish Study Group on Antibiotic Use.

Scand J Infect Dis. 2004;36(2):134-8.

PMID:
15061669
40.

Perception of risk factors for infusion phlebitis among Swedish nurses: a questionnaire study.

Lanbeck P, Odenholt I, Paulsen O.

J Infus Nurs. 2004 Jan-Feb;27(1):25-30.

PMID:
14734984
41.
42.
43.
44.

Activity of three disinfectants and acidified nitrite against Clostridium difficile spores.

Wullt M, Odenholt I, Walder M.

Infect Control Hosp Epidemiol. 2003 Oct;24(10):765-8.

PMID:
14587940
45.

Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.

Odenholt I, Löwdin E, Cars O.

Antimicrob Agents Chemother. 2003 Oct;47(10):3352-6.

46.

Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis.

Lanbeck P, Odenholt I, Paulsen O.

Scand J Infect Dis. 2003;35(6-7):397-400.

PMID:
12953952
47.
48.

Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.

Knudsen JD, Odenholt I, Erlendsdottir H, Gottfredsson M, Cars O, Frimodt-Møller N, Espersen F, Kristinsson KG, Gudmundsson S.

Antimicrob Agents Chemother. 2003 Aug;47(8):2499-506.

50.

Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests.

André M, Odenholt I, Schwan A, Axelsson I, Eriksson M, Hoffman M, Mölstad S, Runehagen A, Lundborg CS, Wahlström R; Swedish Study Group on Antibiotic Use.

Scand J Infect Dis. 2002;34(12):880-6.

PMID:
12587619

Supplemental Content

Loading ...
Support Center